hrp0098p2-92 | Fat, Metabolism and Obesity | ESPE2024

Can asprosin be used as a diagnostic biomarker for non-alcoholic fatty liver disease in obese children?

Tuhan Hale , Singin Berna , Donbaloğlu Zeynep , Özdem Sebahat , Parlak Mesut

Objective: As obesity rates rise among children, non-alcholic fatty liver disease (NAFLD) is becoming more prevalent. Although liver biopsy is considered the gold standard for diagnosing NAFLD, it is an invasive procedure and not practical for screening. Asprosin, a recently unveiled adipokine, is released in response to fasting. In this study, we aim ed to investigate the diagnostic value of asprosin for NAFLD in obese patients....

hrp0095p1-127 | Growth and Syndromes | ESPE2022

Treatment response to growth hormone in a patient with heterozygous ROR2 mutation

Berna Celik Nur , Sezer Abdullah , Elmaogullari Selin , Savas-Erdeve Senay , Cetinkaya Semra

Introduction: ‘Receptor tyrosine kinase-like orphan receptor 2 (ROR2)’ is a transmembrane protein tyrosine kinase encoded by the ROR2 gene. Pathogenic mutations in ROR2 are involved in two diseases: biallelic loss-of-function mutations in Robinow syndrome and monoallelic gain-of-function mutations in brachydactyly type B1. Recently, monoallelic loss-of-function mutations in ROR2 have been reported as a cause of isolated short stature. Here we repor...

hrp0089p3-p033 | Bone, Growth Plate & Mineral Metabolism P3 | ESPE2018

A 13 Year-Old Boy Diagnosed as Osteogenesis Omperfecta with Normal Bone Mineral Density

Tınastepe Tuba , Filibeli Berna Eroğlu , Catlı Gonul , Dundar Bumin Nuri

Osteogenesis imperfecta is a hereditary connective tissue disease developing based on the structure or synthesis impairment of type 1 collagen and proceeding with diffuse osteoporosis, fragility, fractures and deformities in bones. Bone mineral density can be at normal or even high levels particularly especially in type I and XIII. Here, a 13 year-old boy diagnosed as osteogenesis imperfecta with normal bone mineral density was presented and treatment results were shared. A 13...

hrp0089p3-p035 | Bone, Growth Plate & Mineral Metabolism P3 | ESPE2018

Our Treatment Experience with Nocturnal Continuous Enteral Calcium Infusion in a Case with Vitamin D Resistance Rickets Type II

Filibeli Berna Eroğlu , Kırbıyık Ozgur , Dundar Bumin Nuri

Introduction: Vitamin D resistant rickets type II (VDDR-II) is a disease with a difficult treatment developed as a result of mutations in VDR gene. Despite high dose active vitamin D and oral calcium treatments, sufficient recovery cannot be achieved mostly. Successful results with intravenous calcium infusion that is an alternative treatment have been reported; however, serious restrictions and complications such as hospitalization, catheter infection, thrombosis, skin necros...

hrp0089p2-p143 | Fat, Metabolism and Obesity P2 | ESPE2018

The Relationship between Anthropometric Measurements and Breast Milk Ghrelin and Nesfatin-1 Levels in Infants with Small for Gestational Age

Filibeli Berna Eroğlu , Karabulut Melike , Aksun Saliha , Catlı Gonul , Dundar Bumin Nuri

Introduction: It has been suggested that adipokines found in breast milk and may be effective in early growth of infants.Purpose: It was aimed to evaluate the relationship between total ghrelin (TGh) and nesfatin-1 levels in breast milk with anthropometric measurements in the first 4 months of life in infants with small for gestation age (SGA) showing fast growth pattern.Method: A total of 20 SGA and 20 control infants with appropr...

hrp0089p2-p174 | Fat, Metabolism and Obesity P2 | ESPE2018

CAN Triponderal Mass Index be a New Indicator in the Predicting Cardiometabolic Risk in Obese Adolescents?

Cingoz Gulten , Filibeli Berna Eroğlu , Dundar Bumin Nuri , Catlı Gonul

Introduction: BMI is claimed to be unreliable in the determination of body fat rate and cardiometabolic risk. Troublesome and reproducibility low measurements like waist circumference, waist circumference/height rate are used in the evaluation of cardiometabolic risk. Triponderal mass index (TMI; weight/height3), however, is suggested to be superior BMI in determining body fat rate and obesity.Purpose: In this study TMI’s relationship wit...

hrp0097p1-358 | Pituitary, Neuroendocrinology and Puberty | ESPE2023

Do gonadotropin releasing hormone analogues increase the total body fat mass and body mass index in girls with idiopathic central precocious puberty?

Donbaloğlu Zeynep , Singin Berna , Barsal Cetiner Ebru , Aydin Behram Bilge , Bedel Aynur , Tuhan Hale , Parlak Mesut

Aim: Gonadotropin-releasing hormone analogues (GnRHa) are widely used in the treatment of idiopathic central precocious puberty (ICPP) cases due to premature maturation of the hypothalamus-pituitary-gonad axis. The effect of GnRHa therapy on body weight and fat distribution is controversial in the literature. We aimed to examine the anthropometric measurements and body composition analysis of the girls with ICPP and to investigate the effect of related factors...

hrp0095p2-269 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | ESPE2022

A Case of Under virilized Male with 18q Partial Monosomy and 10p Duplication

Arı Hasan , Sezer Abdullah , Berna Çelik Ertas Nur , Ozkaya Donmez Beyhan , Savas Erdeve Senay , Cetinkaya Semra

Objective: Monosomy 18q and 10p duplications rare chromosomal disorders that are caused by deletion of a part of the long arm (q) of chromosome 18 and duplication of genetic material on the short arm (P) of chromosome 10 respectively. In both disorders the phenotype is highly variable and; includes short stature, developmental delay, hypotonia, and facial dysmorphic features. Also, genital abnormalities could occur in both disorders. Genital abnormalities (cry...

hrp0092p1-143 | Thyroid | ESPE2019

Biotine Interference in a Patient with Non-Clinic High Thyroid Hormone Levels

Ayranci Ilkay , Filibeli Berna Eroglu , Manyas Hayrullah , Dündar Bumin Nuri , Çatli Gönül

Introduction: Differential diagnosis of thyroid hormone resistance (beta) and TSHoma should be made in patients with high free thyroxine (f-T4) and free triiodothyronine (f-T3) and non-suppressed thyroid stimulating hormone (TSH) levels. The aim of this study was to present the results of etiological research in a patient with Down syndrome who was clinically euthyroid and had high levels of f-T4, f-T3, normal TSH levels.Case</st...

hrp0089p3-p034 | Bone, Growth Plate &amp; Mineral Metabolism P3 | ESPE2018

A Rare Cause of Hypercalcemia in Childhood: Hypercalcemia Associated with Parathormon-Related Peptid

Catlı Gonul , Filibeli Berna Eroğlu , Demir Belde Kasap , Mutlubaş Fatma , Dundar Bumin Nuri

Introduction: Parathormone-related peptide (PTHrP) regulates tissue calcium concentration by acting in paracrine or autocrine ways. It is mostly responsible for paraneoplastic hypercalcemia seen in adults. Paraneoplastic hypercalcemia in children is rarely reported in cancers such as ALL, medulloblastoma and hepatoblastoma (0.4–0.7%). In experimental studies, PTHrP is shown to be synthesized apart from neoplastic tissue (glomerulus and tubule cells).<p class="abstext"...